Britain first to approve Oxford-AstraZeneca's COVID-19 vaccine, rollout starts Monday - The Globe and Mail | Canada News Media
Connect with us

Business

Britain first to approve Oxford-AstraZeneca's COVID-19 vaccine, rollout starts Monday – The Globe and Mail

Published

 on


AstraZeneca’s logo is reflected in a drop on a syringe needle in this illustration taken November 9, 2020.

DADO RUVIC/Reuters

British regulators have approved a vaccine developed by Oxford University and AstraZeneca that scientists say will massively boost efforts to combat the COVID-19 pandemic.

Unlike the vaccines currently in use – made by BioNTech-Pfizer and Moderna – the Oxford-AstraZeneca vaccine can be stored in regular refrigerators, and it has been priced far lower. Scientists say that will make it easier to distribute the vaccine to doctors’ offices, seniors’ homes and throughout developing countries. AstraZeneca said it will produce three billion doses on a not-for-profit basis throughout the pandemic. The company added on Wednesday that it could soon start producing two million doses a week.

The British government has bet heavily on the Oxford-AstraZeneca vaccine and ordered 100 million doses, enough to cover 50 million people since it requires two doses. The first batch is set to arrive in the country this week and inoculations will begin on Monday. Initial doses will be given to as many people as possible with the second dose coming up to 12 weeks later.

Story continues below advertisement

The approval was “truly fantastic news – and a triumph for British science,” Prime Minister Boris Johnson said on Twitter Wednesday. “We will now move to vaccinate as many people as quickly as possible.”

The U.K. has already vaccinated around 800,000 people with the BioNTech-Pfizer vaccine. But that vaccine must be stored at -70 C, while the Oxford-AstraZeneca drug can be kept in fridges at between 2 and 8 C. It also costs around $5 a dose, compared with $26 for the BioNTech-Pfizer vaccine and $43 for Moderna’s.

The approval by the Medicines and Healthcare products Regulatory Agency was announced at a critical moment in the U.K. The country has been struggling with a rampant surge in COVID-19 infections, which scientists believe could be linked to a more contagious variant of the virus that has emerged in recent weeks. That variant has spread to dozens of countries, including Canada, despite bans on British travellers.

COVID-19 news: Updates and essential resources about the pandemic

The number of daily cases in Britain hit a record high of more than 53,000 on Tuesday, and hospital admissions have reached levels not seen since the pandemic began last March. Much of the country has been put under near total lockdown, and on Wednesday, Health Secretary Matt Hancock is expected to announce further restrictions.

“The regulator’s assessment that this is a safe and effective vaccine is a landmark moment,” said Professor Andrew Pollard, director of the Oxford Vaccine Group. “Though this is just the beginning, we will start to get ahead of the pandemic, protect health and economies when the vulnerable are vaccinated everywhere, as many as possible as soon as possible.”

The Oxford-AstraZeneca vaccine has been in development since last January. It uses a weakened version of a common cold virus that causes infections in chimpanzees but is harmless to humans. Once modified with the genetic sequencing of the spike protein found in COVID-19, the vaccine prompts the human immune system to react.

That’s different from the Pfizer-BioNTech and Moderna vaccines, which involve messenger RNA, or genetic coding, that instructs the vaccinated person’s cells to produce the viral protein, or antigen. That gives the immune system a preview of what the real virus will look like, without causing illness, so it can build defences.

Story continues below advertisement

Approval of the Oxford-AstraZeneca vaccine has taken longer than the other two vaccines because of complications in the testing process.

Initially, the vaccine was supposed to be administered in two full doses, as with the Pfizer-BioNTech and Moderna vaccines. However, a mistake in the early trials saw only half a dose administered at first, followed by a full second dose. That combination proved to be more effective, yielding 90-per-cent protection as opposed to 62 per cent for the two full doses. By contrast, the two other vaccines showed 95-per-cent efficacy during trials.

The MHRA has approved the two-full-dose regime of the Oxford-AstraZeneca vaccine and said that further data from the trials showed that it was 70-per-cent effective after the initial dose. It was 80-per-cent effective after the second dose, the agency added on Wednesday.

Prof. Sir Munir Pirmohamed, chair of the MHRA’s Commission on Human Medicine’s Expert Working Group, said that an analysis of data from the half-dose, full-dose combination found that the results had not been borne out.

June Raine, chief executive of the MHRA, said data showed that the Oxford-AstraZeneca vaccine was effective 21 days after the first dose. She added that initial doses of the Oxford-AstraZeneca and Pfizer-BioNTech offered enough protection that the second doses could be administered up to three months later.

“The public and everyone who’s listening can be absolutely confident that the scientific rigour of our assessment has been as we would normally do it according to guidelines and standards,” Dr. Raine said. “These are difficult times for so many of us, but vaccines such as this one have the potential to save many lives and will see us come through.”

Story continues below advertisement

Dr. Pirmohamed also said the MHRA was not recommending mixing the vaccines – for example giving an initial dose of one vaccine and a second dose of another – but that studies were under way to see whether that would be possible in future.

Public-health officials and scientists said approving the Oxford-AstraZeneca vaccine was a critical moment in the pandemic. “At a time when we see the pandemic accelerating beyond our control, a rapid, efficient vaccination program with good population coverage is our only way out,” said Daniel Altmann, professor of immunology at Imperial College London. “With two vaccines now in the rollout and very substantially more doses, it starts to look realistic that this could be achievable by the spring or early summer.”

How the Oxford-AstraZeneca drug works

16/16

14/14

11/11

The Oxford University and AstraZeneca Covid-19

vaccine can prevent up to 90 per cent of people

contracting coronavirus when it is administered as

a half dose followed by a full dose

at least one month apart

Spike

protein

Spike protein:

Gene is cut from

Sars-CoV-2 genome

Virus

genome

Gene: Inserted into DNA

of adenovirus which acts

as vector in vaccine

Adenovirus:

Unable to

cause disease

Vaccine: Induces spike

protein antigen – triggers

antibody immune response

Antibodies

Human immune

system: Produces

antibodies against

spike proteins

Vaccine: Can be

stored in refrigerator

at 2-8°C. Two doses

of vaccine are

required

graphic news, SOURCE: Reuters; Oxford

Vaccine Trial; University of Oxford

16/16

14/14

11/11

The Oxford University and AstraZeneca Covid-19 vaccine

can prevent up to 90 per cent of people contracting

coronavirus when it is administered as a half dose

followed by a full dose at least one month apart

Spike

protein

Spike protein:

Gene is cut from

Sars-CoV-2 genome

Virus

genome

Gene: Inserted into DNA

of adenovirus which acts

as vector in vaccine

Adenovirus:

Unable to

cause disease

Vaccine: Induces spike

protein antigen – triggers

antibody immune response

Antibodies

Human immune

system: Produces

antibodies against

spike proteins

Vaccine: Can be

stored in refrigerator

at 2-8°C. Two doses

of vaccine are

required

graphic news, SOURCE: Reuters; Oxford Vaccine Trial;

University of Oxford

18/18

16/16

13/13

The Oxford University and AstraZeneca Covid-19 vaccine can prevent

up to 90 per cent of people contracting coronavirus when it is administered

as a half dose followed by a full dose at least one month apart

Spike protein

Adenovirus:

Unable to

cause disease

Virus genome

Spike protein:

Gene is cut from

Sars-CoV-2 genome

Gene: Inserted into DNA

of adenovirus which acts

as vector in vaccine

Antibodies

Vaccine: Induces spike

protein antigen – triggers

antibody immune response

Human immune

system: Produces

antibodies against

spike proteins

Vaccine: Can be

stored in refrigerator

at 2-8°C. Two doses

of vaccine are required

graphic news, SOURCE: Reuters; Oxford Vaccine Trial; University of Oxford


The initial COVID-19 vaccinations in Canada and around the world raise questions about how people react to the shot, how pregnant women should approach it and how far away herd immunity may be. Globe health reporter Kelly Grant and science reporter Ivan Semeniuk discuss the answers. The Globe and Mail

Sign up for the Coronavirus Update newsletter to read the day’s essential coronavirus news, features and explainers written by Globe reporters and editors.

Let’s block ads! (Why?)



Source link

Continue Reading

Business

The #1 Skill I Look For When Hiring

Published

 on

File this column under “for what it’s worth.”

“Communication is one of the most important skills you require for a successful life.” — Catherine Pulsifer, author.

I’m one hundred percent in agreement with Pulsifer, which is why my evaluation of candidates begins with their writing skills. If a candidate’s writing skills and verbal communication skills, which I’ll assess when interviewing, aren’t well above average, I’ll pass on them regardless of their skills and experience.

 

Why?

 

Because business is fundamentally about getting other people to do things—getting employees to be productive, getting customers to buy your products or services, and getting vendors to agree to a counteroffer price. In business, as in life in general, you can’t make anything happen without effective communication; this is especially true when job searching when your writing is often an employer’s first impression of you.

 

Think of all the writing you engage in during a job search (resumes, cover letters, emails, texts) and all your other writing (LinkedIn profile, as well as posts and comments, blogs, articles, tweets, etc.) employers will read when they Google you to determine if you’re interview-worthy.

 

With so much of our communication today taking place via writing (email, text, collaboration platforms such as Microsoft Teams, Slack, ClickUp, WhatsApp and Rocket.Chat), the importance of proficient writing skills can’t be overstated.

 

When assessing a candidate’s writing skills, you probably think I’m looking for grammar and spelling errors. Although error-free writing is important—it shows professionalism and attention to detail—it’s not the primary reason I look at a candidate’s writing skills.

 

The way someone writes reveals how they think.

 

  • Clear writing = Clear thinking
  • Structured paragraphs = Structured mind
  • Impactful sentences = Impactful ideas

 

Effective writing isn’t about using sophisticated vocabulary. Hemingway demonstrated that deceptively simple, stripped-down prose can captivate readers. Effective writing takes intricate thoughts and presents them in a way that makes the reader think, “Damn! Why didn’t I see it that way?” A good writer is a dead giveaway for a good thinker. More than ever, the business world needs “good thinkers.”

 

Therefore, when I come across a candidate who’s a good writer, hence a good thinker, I know they’re likely to be able to write:

 

  • Emails that don’t get deleted immediately and are responded to
  • Simple, concise, and unambiguous instructions
  • Pitches that are likely to get read
  • Social media content that stops thumbs
  • Human-sounding website copy
  • Persuasively, while attuned to the reader’s possible sensitivities

 

Now, let’s talk about the elephant in the room: AI, which job seekers are using en masse. Earlier this year, I wrote that AI’s ability to hyper-increase an employee’s productivity—AI is still in its infancy; we’ve seen nothing yet—in certain professions, such as writing, sales and marketing, computer programming, office and admin, and customer service, makes it a “fewer employees needed” tool, which understandably greatly appeals to employers. In my opinion, the recent layoffs aren’t related to the economy; they’re due to employers adopting AI. Additionally, companies are trying to balance investing in AI with cost-cutting measures. CEOs who’ve previously said, “Our people are everything,” have arguably created today’s job market by obsessively focusing on AI to gain competitive advantages and reduce their largest expense, their payroll.

 

It wouldn’t be a stretch to assume that most AI usage involves generating written content, content that’s obvious to me, and likely to you as well, to have been written by AI. However, here’s the twist: I don’t particularly care.

 

Why?

 

Because the fundamental skill I’m looking for is the ability to organize thoughts and communicate effectively. What I care about is whether the candidate can take AI-generated content and transform it into something uniquely valuable. If they can, they’re demonstrating the skills of being a good thinker and communicator. It’s like being a great DJ; anyone can push play, but it takes skill to read a room and mix music that gets people pumped.

 

Using AI requires prompting effectively, which requires good writing skills to write clear and precise instructions that guide the AI to produce desired outcomes. Prompting AI effectively requires understanding structure, flow and impact. You need to know how to shape raw information, such as milestones throughout your career when you achieved quantitative results, into a compelling narrative.

So, what’s the best way to gain and enhance your writing skills? As with any skill, you’ve got to work at it.

Two rules guide my writing:

 

  • Use strong verbs and nouns instead of relying on adverbs, such as “She dashed to the store.” instead of “She ran quickly to the store.” or “He whispered to the child.” instead of “He spoke softly to the child.”
  • Avoid using long words when a shorter one will do, such as “use” instead of “utilize” or “ask” instead of “inquire.” As attention spans get shorter, I aim for clarity, simplicity and, most importantly, brevity in my writing.

 

Don’t just string words together; learn to organize your thoughts, think critically, and communicate clearly. Solid writing skills will significantly set you apart from your competition, giving you an advantage in your job search and career.

_____________________________________________________________________

 

Nick Kossovan, a well-seasoned veteran of the corporate landscape, offers “unsweetened” job search advice. You can send Nick your questions to artoffindingwork@gmail.com.

Continue Reading

Business

Politics likely pushed Air Canada toward deal with ‘unheard of’ gains for pilots

Published

 on

 

MONTREAL – Politics, public opinion and salary hikes south of the border helped push Air Canada toward a deal that secures major pay gains for pilots, experts say.

Hammered out over the weekend, the would-be agreement includes a cumulative wage hike of nearly 42 per cent over four years — an enormous bump by historical standards — according to one source who was not authorized to speak publicly on the matter. The previous 10-year contract granted increases of just two per cent annually.

The federal government’s stated unwillingness to step in paved the way for a deal, noted John Gradek, after Prime Minister Justin Trudeau made it plain the two sides should hash one out themselves.

“Public opinion basically pressed the federal cabinet, including the prime minister, to keep their hands clear of negotiations and looking at imposing a settlement,” said Gradek, who teaches aviation management at McGill University.

After late-night talks at a hotel near Toronto’s Pearson airport, the country’s biggest airline and the union representing 5,200-plus aviators announced early Sunday morning they had reached a tentative agreement, averting a strike that would have grounded flights and affected some 110,000 passengers daily.

The relative precariousness of the Liberal minority government as well as a push to appear more pro-labour underlay the prime minister’s hands-off approach to the negotiations.

Trudeau said Friday the government would not step in to fix the impasse — unlike during a massive railway work stoppage last month and a strike by WestJet mechanics over the Canada Day long weekend that workers claimed road roughshod over their constitutional right to collective bargaining. Trudeau said the government respects the right to strike and would only intervene if it became apparent no negotiated deal was possible.

“They felt that they really didn’t want to try for a third attempt at intervention and basically said, ‘Let’s let the airline decide how they want to deal with this one,'” said Gradek.

“Air Canada ran out of support as the week wore on, and by the time they got to Friday night, Saturday morning, there was nothing left for them to do but to basically try to get a deal set up and accepted by ALPA (Air Line Pilots Association).”

Trudeau’s government was also unlikely to consider back-to-work legislation after the NDP tore up its agreement to support the Liberal minority in Parliament, Gradek said. Conservative Leader Pierre Poilievre, whose party has traditionally toed a more pro-business line, also said last week that Tories “stand with the pilots” and swore off “pre-empting” the negotiations.

Air Canada CEO Michael Rousseau had asked Ottawa on Thursday to impose binding arbitration pre-emptively — “before any travel disruption starts” — if talks failed. Backed by business leaders, he’d hoped for an effective repeat of the Conservatives’ move to head off a strike in 2012 by legislating Air Canada pilots and ground crew to stick to their posts before any work stoppage could start.

The request may have fallen flat, however. Gradek said he believes there was less anxiety over the fallout from an airline strike than from the countrywide railway shutdown.

He also speculated that public frustration over thousands of cancelled flights would have flowed toward Air Canada rather than Ottawa, prompting the carrier to concede to a deal yielding “unheard of” gains for employees.

“It really was a total collapse of the Air Canada bargaining position,” he said.

Pilots are slated to vote in the coming weeks on the four-year contract.

Last year, pilots at Delta Air Lines, United Airlines and American Airlines secured agreements that included four-year pay boosts ranging from 34 per cent to 40 per cent, ramping up pressure on other carriers to raise wages.

After more than a year of bargaining, Air Canada put forward an offer in August centred around a 30 per cent wage hike over four years.

But the final deal, should union members approve it, grants a 26 per cent increase in the first year alone, retroactive to September 2023, according to the source. Three wage bumps of four per cent would follow in 2024 through 2026.

Passengers may wind up shouldering some of that financial load, one expert noted.

“At the end of the day, it’s all us consumers who are paying,” said Barry Prentice, who heads the University of Manitoba’s transport institute.

Higher fares may be mitigated by the persistence of budget carrier Flair Airlines and the rapid expansion of Porter Airlines — a growing Air Canada rival — as well as waning demand for leisure trips. Corporate travel also remains below pre-COVID-19 levels.

Air Canada said Sunday the tentative contract “recognizes the contributions and professionalism of Air Canada’s pilot group, while providing a framework for the future growth of the airline.”

The union issued a statement saying that, if ratified, the agreement will generate about $1.9 billion of additional value for Air Canada pilots over the course of the deal.

Meanwhile, labour tension with cabin crew looms on the horizon. Air Canada is poised to kick off negotiations with the union representing more than 10,000 flight attendants this year before the contract expires on March 31.

This report by The Canadian Press was first published Sept. 16, 2024.

Companies in this story: (TSX:AC)

Source link

Continue Reading

Business

Federal $500M bailout for Muskrat Falls power delays to keep N.S. rate hikes in check

Published

 on

 

HALIFAX – Ottawa is negotiating a $500-million bailout for Nova Scotia’s privately owned electric utility, saying the money will be used to prevent a big spike in electricity rates.

Federal Natural Resources Minister Jonathan Wilkinson made the announcement today in Halifax, saying Nova Scotia Power Inc. needs the money to cover higher costs resulting from the delayed delivery of electricity from the Muskrat Falls hydroelectric plant in Labrador.

Wilkinson says that without the money, the subsidiary of Emera Inc. would have had to increase rates by 19 per cent over “the short term.”

Nova Scotia Power CEO Peter Gregg says the deal, once approved by the province’s energy regulator, will keep rate increases limited “to be around the rate of inflation,” as costs are spread over a number of years.

The utility helped pay for construction of an underwater transmission link between Newfoundland and Nova Scotia, but the Muskrat Falls project has not been consistent in delivering electricity over the past five years.

Those delays forced Nova Scotia Power to spend more on generating its own electricity.

This report by The Canadian Press was first published Sept. 16, 2024.

The Canadian Press. All rights reserved.

Source link

Continue Reading

Trending

Exit mobile version